Germany Pharmaceutical Excipient Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
The German pharmaceutical excipient market is
estimated to grow at a CAGR of 6.3% during the forecast period. Germany is the
largest contributing country to the European market with a significant growth
rate. The market growth in the country is driven by the increasing demand for
pharmaceutical and biopharmaceutical drugs in the region. Further, the presence
of a large number of biotech companies in the country drives the growth of the
market.
To Request a Sample of our Report on Germany
Pharmaceutical Excipient Market: https://www.omrglobal.com/request-sample/germany-pharmaceutical-excipient-market-growth-analysis
As per Germany Trade & Invest, there are around 679
dedicated biotechnological companies in the country whereas 141 other
biotechnology-active companies in 2018. Around $1.3 billion was invested in
R&D activities in the country. Some of the major companies include 3B
Pharmaceuticals GmbH, BioChem Adda, BioNTech, Glycotope, and others.
In 2017, around 51% of the total drugs approved in
the country were biopharmaceuticals and around 274 biopharmaceutical drugs were
approved in the country which includes vaccines, monoclonal antibodies, and
insulin. The high number of approvals of drugs in the country represents its
increasing demand. This, in turn, supports the growth of the German
pharmaceutical excipient industry.
Further, increasing R&D activities in the
country also support market growth. For instance, in June 2017, the German
Association for Synthetic Biology (GASB) was established in the country with an
aim to augment research activities in the field of synthetic biology in the
country. Some of the major synthetic biology labs operating in the country
include the Institute of Applied Microbiology, Berlin Institute of Technology,
Ansbach University of Applied Sciences, and others.
(Get 15% Discount on Buying this Report)
A full Report of Germany Pharmaceutical Excipient
Market is Available at: https://www.omrglobal.com/industry-reports/germany-pharmaceutical-excipient-market-growth-analysis
Market Coverage
- Market
number available for – 2018-2025
- Base
year- 2018
- Forecast
period- 2019-2025
- Segment
Covered- By Product and By Formulation Type
- Regions
Covered- Germany
- Competitive
Landscape- Merck KGaA, DFE Pharma, BASF SE, Roquette Freres SA, and Meggle
AG.
German Pharmaceutical Excipient Market- Segmentation
By Products
- Solubilizers
& Surfactants/Emulsifiers
- Polyols
- Carbohydrates
- Specialty
Excipients
By Formulations
- Oral
Formulations
- Topical
Formulations
- Parenteral
Formulations
- Other
Formulations
Company
Profiles
·
ABITEC Corp.
·
Overview
·
ABITEC Corp. in Pharmaceutical Excipient Landscape
·
Recent Developments
·
BASF SE
·
Colorcon, Inc.
·
DFE Pharma
·
JRS PHARMA
·
Lyomark Pharma
·
Lubrizol Corp.
·
Merck KGaA
·
Meggle AG
·
Roquette Freres SA
Reasons to Buying
From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries
are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-pharmaceutical-excipient-market-growth-analysis
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment